logoTry Persana

Releaf - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about Releaf including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

Releaf company logo

The UK's fastest-growing medical cannabis clinic; we're changing lives through the power of better health.

Releaf was launched as a HealthTech company dedicated to transforming access to Cannabis Based Products for Medical use in the UK, addressing challenges faced by patients in the medical cannabis space.

HeadquartersLondon, United Kingdom
Team size101-250
Founded2024

What is Releaf? - Company Overview & Details

Releaf is Releaf was launched as a HealthTech company dedicated to transforming access to Cannabis Based Products for Medical use in the UK, addressing challenges faced by patients in the medical cannabis space. Founded in 2024, the company is headquartered in London, United Kingdom.

Who Founded Releaf?

Releaf was founded by Tim Kirby, Oliver Soar.

Who are the Key Executives at Releaf? - Leadership Team

Releaf is led by experienced executives in key positions:

Chief Executive Officer (CEO) of Releaf

Tim KirbyCEO

Chief Technology Officer (CTO) of Releaf

Oliver SoarCTO

About Tim Kirby - CEO of Releaf

Tim Kirby serves as the Chief Executive Officer of Releaf, leading the company's strategic vision and operations. Connect with them on LinkedIn for professional insights.

Releaf Company Details & Key Information

Where is Releaf located?

Releaf is headquartered in London, United Kingdom.

How many employees does Releaf have?

Releaf has 101-250 employees.

When was Releaf founded?

Releaf was founded in 2024.

Releaf Official Website

How much funding has Releaf raised?

Releaf has raised $6.7 Million across 1 funding rounds. The most recent funding was completed on 2024-02-01.

Funding Overview

Releaf raised $6.7 Million in a Series B funding round to expand its HealthTech platform and improve patient access to medical cannabis.

$6.7 Million
Total Funding Raised
1
Funding Rounds
2024-02-01
Latest Round

Releaf Funding History

Series B
2024-02-01
$6.7 Million

Who are the key investors in Releaf?

Investor Information Not Available

Detailed information about Releaf investors is not currently available in our database.

What are Releaf's future plans?

Releaf Releaf aims to continue integrating its platform into the healthcare system, focusing on patient education and expanding its treatment offerings.

Releaf Strategic Outlook

Strategic Focus
Defined
3
Key Challenges
3
Growth Opportunities

What challenges does Releaf face?

Releaf has identified 3 key challenges that need to be addressed for continued growth and success.

Key Challenges for Releaf

1

Fragmented supply chain

2

Regulatory hurdles

3

Patient education on medical cannabis

What opportunities does Releaf have?

Releaf has identified 3 key opportunities for growth and market expansion.

Growth Opportunities for Releaf

1

Growing demand for medical cannabis

2

Expanding patient base

3

Partnerships with pharmaceutical companies

Releaf Strategic Position Summary

Key Focus Areas

Releaf is addressing 3 strategic challenges to strengthen its market position.

Growth Potential

The company has identified 3 key opportunities for expansion and growth.

What are the latest news about Releaf?

Releaf has 2 recent news updates covering key business developments and market activities.

Releaf News Overview

2
Recent Articles
Active
Media Coverage
2025-01-10
Latest Update

What is Releaf in the news for?

Releaf is currently featured in news for Releaf Dispensary Limited launches £2m proprietary tech platform designed to transform how patients access medical cannabis treatment. and other significant business developments.

Recent News Articles About Releaf

Article 1
2025-01-10

Releaf Dispensary Limited launches £2m proprietary tech platform designed to transform how patients access medical cannabis treatment.

UK-based medical cannabis provider Releaf has launched a £2m proprietary tech platform designed to transform how patients access medical cannabis treatment.

digitalhealth.net
Read News
Article 2
2024-10-08

SOMAÍ Pharmaceuticals Inc. partnered with Releaf Dispensary Limited on Oct 9th '24.

SOMAÍ Pharmaceuticals announces partnership with Releaf clinic to bring innovative cannabis solutions to UK patients.

einnews.com
Read News

Releaf FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about Releaf including information about founders, CEO, funding history, investors, headquarters location, and company details. 17 frequently asked questions covering key information about the company.

Releaf Questions & Answers - Company Information

Q1

What is Releaf?

Releaf was launched as a HealthTech company dedicated to transforming access to Cannabis Based Products for Medical use in the UK, addressing challenges faced by patients in the medical cannabis space.

Q2

Who founded Releaf?

Releaf was founded by Tim Kirby, Oliver Soar.

Q3

Who is the CEO of Releaf?

The CEO of Releaf is Tim Kirby. You can find more information about them on their LinkedIn profile.

Q4

How much funding has Releaf raised?

Releaf has raised a total of $$6.7 Million across 1 funding rounds. The most recent funding was completed on 2024-02-01.

Q5

Where is Releaf headquartered?

Releaf is headquartered in London, United Kingdom.

Q6

When was Releaf founded?

Releaf was founded in 2024.

Q7

How many employees does Releaf have?

Releaf has 101-250 employees.

Q8

What is Releaf's official website?

You can visit Releaf's official website at https://releaf.co.uk/.

Q9

What was Releaf's latest funding round?

Releaf's latest funding round was a Series B round of $$6.7 Million completed on 2024-02-01.

Q10

Who is founder?

Tim Kirby

Q11

Who is cto?

Oliver Soar

Q12

What does the company do?

Releaf is a HealthTech company dedicated to transforming access to Cannabis Based Products for Medical use in the UK.

Q13

How much funding?

$6.7 Million

Q14

Latest funding date?

2024-02-01

Q15

What are the challenges?

Fragmented supply chain Regulatory hurdles Patient education on medical cannabis

Q16

What are the opportunities?

Growing demand for medical cannabis Expanding patient base Partnerships with pharmaceutical companies

Q17

Latest news?

UK-based medical cannabis provider Releaf has launched a £2m proprietary tech platform designed to transform how patients access medical cannabis treatment. SOMAÍ Pharmaceuticals announces partnership with Releaf clinic to bring innovative cannabis solutions to UK patients.

More Information About Releaf

For additional details about Releaf, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.